Related Experiment Video
Updated: Jun 24, 2026
09:20
Isolation and Differentiation of Adipose-Derived Stem Cells from Porcine Subcutaneous Adipose Tissues
Published on: March 31, 2016
Luteolin inhibits adipogenic differentiation by regulating PPARgamma activation
Hee-Sook Park1, Soon-Hee Kim, Young Sup Kim
1Department of Biogeron Food Technology, Korea Food Research Institute, Pundang-ku, Songnam, Kyongki-do, Republic of Korea.
Biofactors (Oxford, England)
|April 9, 2009
Summary
Luteolin, a flavonoid, effectively reduces fat cell formation by inhibiting key adipogenic transcription factors, including peroxisome proliferator-activated receptor gamma (PPARγ). This natural compound shows potential for anti-obesity research.
Area of Science:
- Biochemistry
- Cell Biology
- Molecular Biology
Background:
- Luteolin, a natural flavonoid, exhibits various beneficial properties like antioxidant and anti-inflammatory effects.
- Adipogenesis, the process of fat cell differentiation, is a complex mechanism involving specific transcription factors.
Purpose of the Study:
- To investigate the effect of luteolin on adipogenic differentiation in 3T3-L1 preadipocytes.
- To elucidate the molecular mechanisms underlying luteolin's action on fat cell formation.
Main Methods:
- 3T3-L1 preadipocytes were treated with luteolin to assess its impact on lipid accumulation.
- Western blot and RT-PCR were employed to analyze the expression of adipogenic transcription factors (PPARγ and C/EBPα).
- Functional assays in COS-7 cells examined luteolin's effect on PPARγ transactivation.
Main Results:
- Luteolin significantly inhibited intracellular triglyceride accumulation in a dose-dependent manner without inducing cytotoxicity.
- The expression of key adipogenic transcription factors, PPARγ and C/EBPα, was attenuated by luteolin treatment.
- Luteolin suppressed PPARγ transactivation and rosiglitazone-induced adipogenic differentiation in 3T3-L1 cells.
Conclusions:
- Luteolin demonstrates antiadipogenic effects by suppressing the expression of critical adipogenic transcription factors.
- Luteolin inhibits the transactivation of PPARγ, suggesting a role in regulating fat cell differentiation.
- These findings highlight luteolin's potential as a therapeutic agent for metabolic disorders related to adipogenesis.
